Paper Details

  1. Home
  2. Paper Details

Quinapril in chronic heart failure.

Author: DargieH J, NorthridgeD B

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Quinapril, a nonsulfhydryl ACE inhibitor, was found to improve clinical status and exercise capacity in patients with mild to moderate chronic heart failure. In a large, multicenter, randomized, placebo-controlled study of 225 patients, quinapril significantly improved clinical status and exercise capacity in a dose-related manner, with side effects similar to placebo.
Paper Details　
Original Abstract of the Article :
Angiotensin converting enzyme inhibitors are now firmly established in the treatment of patients with chronic heart failure (CHF). Their beneficial acute and chronic hemodynamic effects are not associated with reflex tachycardia or drug tolerance. Angiotensin converting enzyme inhibitors produce sym...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1093/ajh/3.11s.283s

データ提供：米国国立医学図書館（NLM）

Quinapril: A New Hope for Chronic Heart Failure

Chronic heart failure, like a relentless desert wind, can leave patients feeling breathless and exhausted. This article explores the potential of quinapril, an angiotensin-converting enzyme (ACE) inhibitor, as a treatment for chronic heart failure. Imagine a desert traveler seeking a remedy for a debilitating condition. The researchers, like skilled desert healers, investigated the effects of quinapril on patients with chronic heart failure, uncovering its beneficial hemodynamic effects and its ability to improve symptoms and exercise capacity. This research, like a well-placed oasis, offers a ray of hope for patients struggling with chronic heart failure.

Quinapril: A Beacon of Hope in the Desert of Heart Failure

The study found that quinapril significantly improved clinical status and exercise capacity in patients with chronic heart failure, offering a beacon of hope in the desert of this debilitating condition. This research, like a map of the desert, helps us understand the potential benefits of quinapril in treating chronic heart failure and provides valuable information for making informed treatment decisions.

Navigating the Desert of Heart Failure

If you're living with chronic heart failure, it's crucial to work closely with your doctor to develop the best treatment plan for your individual needs. This research, like a guidebook for the desert, provides valuable insights into the potential benefits of quinapril in managing chronic heart failure. Remember, finding the right treatment approach is like finding a hidden oasis, and it takes time, patience, and collaboration with your healthcare provider.

Dr. Camel's Conclusion

This research is a reminder that the desert of chronic heart failure can be a challenging landscape to navigate. It highlights the potential of quinapril as a valuable treatment option, offering a glimmer of hope for patients struggling with this debilitating condition. It's a reminder that the quest for optimal heart health requires a collaborative approach between patient and doctor, with a focus on finding the right tools and strategies for managing the complexities of this journey.

Date :
  1. Date Completed 1991-02-07
  2. Date Revised 2019-05-10
Further Info :

Pubmed ID

2261147

DOI: Digital Object Identifier

10.1093/ajh/3.11s.283s

Related Literature

Article Analysis
・Side Effects of quinapril
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.